Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
NCT04634916
This study is recruiting at 14 US sites in 8 states, according to its ClinicalTrials.gov record last updated .
Summary
A prospective, single-arm, multi-center post-market surveillance study of the BD® WavelinQ™ EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Kidney Disease, End-Stage
- End-stage Renal Disease
- Arteriovenous Fistula
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- C. R. Bard
- Last updated on ClinicalTrials.gov
- August 10, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 2
- California Institute of Renal Research · La Jolla, CA
- San Francisco Vein & Vascular · San Francisco, CA
Florida · 2
- First Coast Cardiovascular Institute Pa · Jacksonville, FL
- Radiology and Imaging Specialists · Lakeland, FL
Massachusetts · 3
- Kidney Care and Transplant Services of NE · Springfield, MA
- Kidney Care & Transplant Services of New England · West Springfield, MA
- UMass Chan School of Medicine · Worcester, MA
New York · 1
- Albany Medical Center · Albany, NY
Ohio · 1
- ProMedica Toledo Hospital · Toledo, OH
Pennsylvania · 1
- Butler Memorial Hospital · Butler, PA
Tennessee · 2
- Vascular Institute of Chattanooga · Chattanooga, TN
- Bluff City Vascular · Memphis, TN
Texas · 2
- University of Texas Southwestern Medical Center · Dallas, TX
- Houston Methodist · Houston, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.